[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Europe, BA 5 and monkeypox next", "description": "European Centre for Disease Prevention and Control BA.4 and BA.5\n \nhttps://www.ecdc.europa.eu/en/covid-19/variants-concern\n\nhttps://www.ecdc.europa.eu/en/news-events/epidemiological-update-sars-cov-2-omicron-sub-lineages-ba4-and-ba5\n\n12th May, ECDC reclassified omicron subvariants, BA.4 and BA.5 as VOCs\n\nFirst detected in South Africa in January and February 2022\n\nNow dominant in SA\n\nBoth lineages contain L452R, F486V, and R493Q in the spike receptor binding domain\n\nSignificant change in antigenic properties of BA.4 and BA.5 compared to BA.1 and BA.2\n\nPortugal\n\nBA.5, increasing trend in variant proportions\n\nWith increase in case numbers and test positivity rate\n\nPortuguese National Institute of Health\n\nBA.5 already accounted for ~37% of positive cases as of 8 May\n\nDaily growth advantage for BA.5 over BA.2 is 13%\n\n(SA estimated 12% daily growth advantage)\n\nBA.5 will become the dominant variant in Portugal by 22 May 2022\n\nGrowth advantage for BA.4 and BA.5\n\nEvade immune protection induced by prior infection and/or vaccination, \n\nparticularly if this has waned over time\n\nBA.4 and BA.5 are capable of escaping immune protection induced by infection with BA.1\n\nNo indication of any change in severity for BA.4/BA.5 compared to previous Omicron lineages.\n\nThese variants could cause a significant overall increase in cases in Europe\n\nIf COVID-19 case numbers increase substantially, some level of increased hospital\n\nCountries should have plans in place for the rapid deployment of booster doses in these population groups.\n\nOur world in data\n\nhttps://ourworldindata.org/coronavirus\n\nUS variant nowcast\n\nhttps://covid.cdc.gov/covid-data-tracker/#variant-proportions\n\nSouth Africa\n\nhttps://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/\n\nSARS-CoV-2 variants of concern and variants under investigation in England \n\nTechnical briefing 41 \n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1073698/Technical-Briefing-41.pdf\n\nV-22APR-03 (Omicron sub-lineage BA.4) and V-22APR-04 (Omicron sub-lineage BA.5) \nAs of 3 May 2022\n\nBA.4 40 genomes\n\nBA.5 19 genomes \n\nMonkeypox update\n\nhttps://pubmed.ncbi.nlm.nih.gov/23142251/\n\nMassachusetts public health officials confirm case of monkeypox\n\nhttps://www.mass.gov/news/massachusetts-public-health-officials-confirm-case-of-monkeypox\n\nAn adult male with recent travel to Canada\n\nAustralia\n\nhttps://www.theguardian.com/australia-news/2022/may/20/australias-first-probable-case-of-monkeypox-virus-identified-in-nsw\n\nVictoria, man 30s traveller from UK\n\nNSW, man 40s traveller from Europe\n\nJennifer McQuiston at the US Centers for Disease Control and Prevention\n\nhttps://www.statnews.com/2022/05/18/spain-portugal-report-monkeypox-cases-raising-specter-of-wider-outbreak/?utm_source=Nature+Briefing&utm_campaign=7a51987021-briefing-dy-20220519&utm_medium=email&utm_term=0_c9dfd39373-7a51987021-44762053\n\nWe\u2019re seeing this expansion of confirmed and suspect cases globally\n\nWe have a sense that no one has their arms around this to know how large and expansive it might be\n\nMaria Van Kerkhove, emerging diseases and zoonoses unit, World Health Organization\n\nPositive cases identified in the U.K., Portugal, and Spain (Sweden)\n\nAnd we expect there will be others", "link": "https://www.youtube.com/watch?v=3SsxmswNo4Y", "date_published": "2022-05-20 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]